Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic

Aged Female Head and Neck Neoplasms / diagnostic imaging Humans Male Middle Aged Misonidazole / analogs & derivatives Positron Emission Tomography Computed Tomography Probability Prospective Studies
18F-FMISO PET/CT TCP model head and neck cancer hypoxia outcome prediction radiotherapy

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2019
Historique:
received: 21 02 2019
accepted: 02 05 2019
pubmed: 12 5 2019
medline: 1 7 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

Our purpose was to evaluate an imaging parameter-response relationship between the extent of tumor hypoxia quantified by dynamic

Identifiants

DOI: 10.2967/jnumed.119.227744 PMID: 31076504 PMC: PMC6894382
pubmed: 31076504
pii: jnumed.119.227744
doi: 10.2967/jnumed.119.227744
pmc: PMC6894382
doi:

Substances chimiques

fluoromisonidazole 082285VIDF
Misonidazole 8FE7LTN8XE

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1698-1704

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Eur Radiol. 2014 Aug;24(8):1964-70
pubmed: 24895030
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):240-248
pubmed: 26338178
J Nucl Med. 2017 Jun;58(6):911-919
pubmed: 28232611
Radiother Oncol. 2014 Dec;113(3):310-6
pubmed: 25544647
Radiother Oncol. 2013 Sep;108(3):511-6
pubmed: 23849686
Radiother Oncol. 2019 Jan;130:97-103
pubmed: 30293643
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1544-52
pubmed: 24570097
Cancer Res. 2018 Aug 15;78(16):4774-4785
pubmed: 29945958
Eur J Cancer. 2009 Nov;45(16):2906-14
pubmed: 19699082
Radiother Oncol. 2012 Oct;105(1):14-20
pubmed: 23083497
Clin Cancer Res. 2006 Sep 15;12(18):5435-41
pubmed: 17000677
Radiother Oncol. 2017 Sep;124(3):533-540
pubmed: 28843726
Radiother Oncol. 2010 Sep;96(3):275-6
pubmed: 20708810
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):515-21
pubmed: 17398015
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1840-9
pubmed: 26136164
J Nucl Med. 2010 Jan;51(1):37-45
pubmed: 20008982
J Nucl Med. 2016 Mar;57(3):334-41
pubmed: 26609178
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1682-1691
pubmed: 28540417
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):9-17
pubmed: 27511842
J Nucl Med. 2017 Jul;58(7):1045-1053
pubmed: 28254869
Radiother Oncol. 2012 Oct;105(1):21-8
pubmed: 23022173
Radiother Oncol. 2012 Jan;102(1):122-9
pubmed: 21996521
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):161-169
pubmed: 29075831
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):235-42
pubmed: 18086391
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):551-60
pubmed: 10837935
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):291-300
pubmed: 17448882
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2139-2146
pubmed: 27251643
Clin Cancer Res. 2016 Jun 1;22(11):2639-49
pubmed: 26755529
Radiother Oncol. 2017 Sep;124(3):526-532
pubmed: 28434798
Cancer Res. 2011 Sep 1;71(17):5923-31
pubmed: 21846821
Nat Rev Clin Oncol. 2012 Dec;9(12):674-87
pubmed: 23149893
J Nucl Med. 2017 Oct;58(10):1567-1573
pubmed: 28360207
Radiother Oncol. 2015 Oct;117(1):113-7
pubmed: 26432067
Acta Oncol. 2015;54(9):1364-9
pubmed: 26481464
Radiat Oncol. 2018 Aug 29;13(1):159
pubmed: 30157883
Phys Med Biol. 2005 May 21;50(10):2209-24
pubmed: 15876662
Clin Cancer Res. 2014 Dec 15;20(24):6389-97
pubmed: 25316821
J Nucl Med. 2017 Jul;58(7):1072-1080
pubmed: 28183993
Radiother Oncol. 1996 Oct;41(1):31-9
pubmed: 8961365

Auteurs

Daniela Thorwarth (D)

Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany daniela.thorwarth@med.uni-tuebingen.de.
German Cancer Consortium, Tübingen, Germany, and German Cancer Research Center, Heidelberg, Germany.

Stefan Welz (S)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.

David Mönnich (D)

Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.

Christina Pfannenberg (C)

Diagnostic and Interventional Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.

Konstantin Nikolaou (K)

Diagnostic and Interventional Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.

Matthias Reimold (M)

Department of Nuclear Medicine, University of Tübingen, Tübingen, Germany.

Christian La Fougère (C)

Department of Nuclear Medicine, University of Tübingen, Tübingen, Germany.

Gerald Reischl (G)

Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.

Paul-Stefan Mauz (PS)

Department of Otorhinolaryngology, University of Tübingen, Tübingen, Germany.

Frank Paulsen (F)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.

Markus Alber (M)

Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany; and.

Claus Belka (C)

German Cancer Consortium, Tübingen, Germany, and German Cancer Research Center, Heidelberg, Germany.
Department of Radiation Oncology, LMU Munich, München, Germany.

Daniel Zips (D)

German Cancer Consortium, Tübingen, Germany, and German Cancer Research Center, Heidelberg, Germany.
Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Nitroimidazoles › Misonidazole › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Prospective Evaluation of a Tumor Control...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Prospective Evaluation of a Tumor Control...